Assessment of Bayesian Hierarchical Covariance Structures for Modeling Spatial Protein Imaging Data
Alex Soupir
Co-Author
Biostatistics and Bioinformatics Shared Resource, Moffitt Cancer Center
Mary Townsend
Co-Author
Division of Oncological Sciences, Knight Cancer Institute Oregon Health and Science University
Andrew Lawson
Co-Author
Medical University of South Carolina, College of Medicine
Kathryn Terry
Co-Author
Brigham and Women’s Hospital and Harvard Medical School
Sunday, Aug 3: 4:20 PM - 4:35 PM
1955
Contributed Papers
Music City Center
Examining the tumor immune microenvironment (TIME) has been revolutionized by advancements in spatial proteomic imaging techniques. These techniques assess multiple markers simultaneously to differentiate different immune cell populations in the TIME. The analysis of these immune profiles has become increasingly significant with the progress of immunotherapy treatments. The over-dispersed nature of the cell count data is accounted for by modeling the count data using a beta-binomial distribution. To account for the correlation between the different cell populations in the TIME (i.e., T cells and Cytotoxic T cells), we developed a Bayesian hierarchical beta-binomial model. The Bayesian model can incorporate different covariance (or relationship) structures between the different immune cell populations to incorporate immune differentiation paths. To illustrate the Bayesian model and different covariance structures that are possible, the model is applied to spatial proteomic data from three large epidemiologic cohorts (N = 486) looking at the TIME of ovarian cancer.
Bayesian
beta-binomial model
covariance structures
hierarchical
spatial protein imaging data
tumor immune microenvironment
Main Sponsor
Biometrics Section
You have unsaved changes.